Jeffrey Alan Hawkins Sells 12,149 Shares of Quantum-Si (NASDAQ:QSI) Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 12,149 shares of Quantum-Si stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $0.83, for a total value of $10,083.67. Following the transaction, the chief executive officer owned 3,859,847 shares of the company’s stock, valued at approximately $3,203,673.01. This represents a 0.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

Jeffrey Alan Hawkins also recently made the following trade(s):

• On Friday, March 20th, Jeffrey Alan Hawkins sold 11,628 shares of Quantum-Si stock. The shares were sold at an average price of $0.85, for a total value of $9,883.80.

Quantum-Si Trading Down 6.5%

NASDAQ QSI opened at $0.81 on Friday. The stock has a market capitalization of $174.98 million, a price-to-earnings ratio of -1.56 and a beta of 3.00. The stock has a 50-day moving average of $1.02 and a 200 day moving average of $1.35. Quantum-Si Incorporated has a twelve month low of $0.79 and a twelve month high of $3.10.

Quantum-Si (NASDAQ:QSI) last posted its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.06. Quantum-Si had a negative net margin of 4,160.06% and a negative return on equity of 43.90%. The firm had revenue of $0.45 million for the quarter, compared to the consensus estimate of $0.76 million. Equities analysts predict that Quantum-Si Incorporated will post -0.65 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on QSI shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Quantum-Si in a research note on Monday, December 29th. Canaccord Genuity Group cut their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, March 4th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $3.25.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Prudential Financial Inc. purchased a new position in shares of Quantum-Si during the second quarter worth about $25,000. Cerity Partners LLC purchased a new stake in shares of Quantum-Si in the 2nd quarter valued at about $29,000. Capital Investment Advisory Services LLC lifted its holdings in shares of Quantum-Si by 100.0% in the 3rd quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock valued at $28,000 after purchasing an additional 10,000 shares during the last quarter. Elite Life Management LLC acquired a new stake in shares of Quantum-Si in the 3rd quarter valued at about $29,000. Finally, HBK Sorce Advisory LLC acquired a new stake in shares of Quantum-Si in the 3rd quarter valued at about $30,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.